Expression and functional research of TLR4 in human colon carcinoma

American Journal of the Medical Sciences

Volumn 339, Issue 4, 2010, Pages 319-326

  Tang, Xiao Yan ^a   Zhu, You Qing ^b   Wei, Bai ^b   Wang, Hua ^a  

^a General Department of Zhongnan Hospital   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Apoptosis resistance; Colon carcinoma; Immune escape; NF B; TLR4

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VASCULOTROPIN; TLR4 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER RESISTANCE; CARCINOMA CELL; CELL PROLIFERATION; COLON CARCINOMA; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR ESCAPE; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CELL TRANSFORMATION; COLON TUMOR; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOSUPPRESSIVE TREATMENT; METABOLISM; PATHOLOGY; PHYSIOLOGY; RAT; TUMOR CELL CULTURE;

ANIMALS; APOPTOSIS; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOSUPPRESSION; RATS; TOLL-LIKE RECEPTOR 4; TUMOR CELLS, CULTURED; TUMOR ESCAPE;

EID: 77950930729     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181cef1b7     Document Type: Article

References (38)

1. Taguchi T, Mitcham JL, Dower SK, et al. Chromosomal localization of TIL, a gene encoding a protein related to the Drosophila transmembrane receptor Toll, to human chromosome 4p14. Genomics 1996;32:486-488 (Pubitemid 26094358)
2. Medzhitov R, Preston-Hurlburt P, Janeway Jr CA. A human homologue of the Drosophila Toll proteins signals activation of adaptive immunity. Nature 1997;388:394-397 (Pubitemid 27334820)
3. Zhang Z, Schluesener HJ. Mammalian Toll-like receptors: from endogenous ligands to tissue regeneration. Cell Mol Life Sci 2006;63: 2901-2907 (Pubitemid 46072297)
4. Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003;21:335-376 (Pubitemid 37174535)
5. Kawai T, Akira S. Pathogen recognition with Toll-like receptors. Curr Opin Immunol 2005;17:338-344 (Pubitemid 40848534)
6. Biragyn A, Ruffini PA, Leifer CA, et al. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 2002;298: 1025-1029 (Pubitemid 35247310)
7. Guillot L, Balloy V, McCormack FX, et al. Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J Immunol 2002;168:5989-5992 (Pubitemid 34620010)
8. Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through Toll-like receptor 4. J Immunol 2001;167:2887-2894
9. Termeer C, Benedix F, Sleeman J, et al. Oligosaccharides of Hyaluronan activate dendritic cells via Toll-like receptor 4. J Exp Med 2002;195:99-111. (Pubitemid 34074500)
10. Lancaster GI, Khan Q, Drysdale P, et al. The physiological regulation of Toll like receptor expression and function in humans. J Physiol 2005;563:945-955 (Pubitemid 40425607)
11. Lin WW, Karin M. A cytokine-mediated link between innate immunity, inflammation, and cancer. J Clin Invest 2007;117:1175-1183 (Pubitemid 46718402)
12. Hofseth LJ, Wargovich MJ. Inflammation, cancer, and targets of ginseng. J Nutr 2007;137:183s-185s.
13. Vicari AP, Caux C, Trinchieri G. Tumor escape from immune surveillance through dendritic cell inactivation. Semin Cancer Biol 2002;12:33-42. (Pubitemid 34087896)
14. Chen KQ, Huang J, Gong WH, et al. Toll-like receptors in inflammation, infection and cancer. Int Immunopharmacol 2007;7:1271-1285 (Pubitemid 47126372)
15. He WG, Liu QY, Wang L, et al. TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Mol Immunol 2007;44:2850-2859 (Pubitemid 46412506)
16. Franchimont D, Vermeire S, EI Housni H, et al. Deficient hostbacteria interactions in inflammatory bowel disease? The Toll-like receptor TLR-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 2004;53:987-992 (Pubitemid 38824157)
17. Toiyama Y, Araki T. The expression patterns of Toll-like receptors in the ileal pouch mucosa of postoperative ulcerative colitis patients. Surg Today 2006;36:287-290 (Pubitemid 43288728)
18. Fukata M, Chen A, Vamadevan AS, et al. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 2007;133:1869-1881 (Pubitemid 350186162)
19. Tang XY, Zhu YQ, T WH, et al. Synergistic effect of triptolide combined with 5-fluorouracil on colon carcinoma. Postgrad Med J 2007;83:338-343
20. Lee SK, Kim T II, Kim YK, et al. Cellular differentiation-induced attenuation of LPS response in HT-29 cells is related to the downregulation of TLR4 expression. Biochem Biophys Res Commun 2005; 337:457-463
21. An H, Yu Y, Zhang M, et al. Involvement of ERK, p38 and NFkappaB signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells. Immunology 2002;106:38-45. (Pubitemid 34437875)
22. Kawai T, Akira S. TLR signaling. Semin Immunol 2007;19:24-32. (Pubitemid 46498752)
23. Fang JY, Richardson BC. The MAPK signalling pathways and colorectal cancer. Lancet Oncol 2005;6:322-327
24. Piotrowska A, Izykowska I, Podhorska-Okolow M, et al. The structure of NF- kappaB family proteins and their role in apoptosis. Postepy Hig Med Dosw 2008;62:64-74.
25. Abreu MT, Arnold ET, Thomas LS, et al. TLR4 and MD-2 expression is regulated by immune-mediated signals in human intestinal epithelial cells. J Biol Chem 2002;277:20431-20437
26. Hofmanova J, Vaculova A, Hyzd'alova M, et al. Response of normal and colon cancer epithelial cells to TNF-family apoptotic inducers. Oncol Rep 2008;19:567-573 (Pubitemid 351176122)
27. Re F, Strominger JL. Heterogeneity of TLR-induced responses in dendritic cells: from innate to adaptive immunity. Immunobiology 2004;209:191-198 (Pubitemid 39255703)
28. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001;2:675-680 (Pubitemid 32747155)
29. Szczepajski M, Stelmachowska M, Stryczyjski G, et al. Assessment of expression of Toll-like receptors 2, 3 and 4 in laryngeal carcinoma. Eur Arch Otorhinolaryngol 2007;264:525-530 (Pubitemid 46569951)
30. Molteni M, Marabella D, Orlandi C, et al. Melanoma cell lines are responsive in vitro to lipopolysaccharide and express TLR-4. Cancer Lett 2006;235:75-83.
31. Tichomirowa M, Theodoropoulou M, Lohrer P, et al. Bacterial endotoxin (lipopolysaccharide) stimulates interleukin-6 production and inhibits growth of pituitary tumour cells expressing the Toll-like receptor 4. J Neuroendocrinol 2005;17:152-160 (Pubitemid 40553014)
32. Schmausser B, Andrulis M, Endrich S, et al. Toll-like receptors TLR4, TLR5 and TLR9 on gastric carcinoma cells: an implication for interaction with Helicobacter pylori. Int J Med Microbiol 2005;295: 179-185 (Pubitemid 40776102)
33. Huang B, Zhao J, Li H. Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res 2005;65:5009-5014 (Pubitemid 40827306)
34. Igney FH, Krammer PH. Immune escape of tumors: apoptosis resistance and tumor counterattack. J Leukoc Biol 2002;71:907-920
35. Melnikova VO, Bar-Eli M. Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8. Pigment Cell Res 2006;19:395-405. (Pubitemid 44326401)
36. Barkett M, Gilmore TD. Control of apoptosis by Rel/NF-kB transcription factors. Oncogene 1999;18:6910-6924
37. Kelly MG, Alvero AB, Chen R, et al. TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res 2006;66:3859-3868
38. Vabulas RM, Wagner H, Schild H. Heat shock proteins as ligands of Toll-like receptors. Curr Top Microbiol Immunol 2002;270:169-184 (Pubitemid 35448160)